SNIP1抗体—艾普蒂

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: TM4 cell lysate, Primary antibody: P10435(SNIP1 Antibody) at dilution 1/1150, Secondary antibody: Goat anti rabbit IgG at 1/5000 dilution, Exposure time: 30 seconds    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human breast cancer tissue using P10435(SNIP1 Antibody) at dilution 1/80. (Original magnification: ×200)    

  
  

**Background of SNIP1 Antibody**

SNIP1 (Smad Nuclear Interacting Protein 1) is a multifunctional protein involved in transcriptional regulation, notably interacting with key signaling pathways such as TGF-β/Smad, NF-κB, and c-Myc. It acts as a co-modulator of transcription factors, influencing processes like cell proliferation, differentiation, and apoptosis. SNIP1’s role in DNA damage response and stem cell maintenance has also been explored, highlighting its importance in both normal physiology and disease.

Antibodies targeting SNIP1 are critical tools for studying its expression, localization, and molecular interactions. These antibodies are commonly used in techniques like Western blotting, immunoprecipitation, and immunofluorescence to detect SNIP1 in cellular or tissue samples. Given SNIP1’s dual role as a tumor suppressor or promoter in context-dependent cancers (e.g., breast, colorectal), SNIP1 antibodies aid in elucidating its mechanistic contributions to oncogenesis and therapy resistance.

Validated SNIP1 antibodies typically demonstrate specificity through knockout cell controls or siRNA-mediated knockdown. Researchers also utilize them to explore SNIP1’s post-translational modifications and partnerships with proteins like p53 or BRCA1. Commercial SNIP1 antibodies are often raised against epitopes within its N-terminal or central regions. Reliable detection of SNIP1 enhances understanding of its regulatory networks, offering potential insights into therapeutic targeting in cancer and other diseases linked to transcriptional dysregulation.